$DCTH
Delcath Systems Inc

2015 Q1 Form 10-Q Financial Statement

#000156459015003441 Filed on May 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q1
Revenue $444.0K $290.0K $310.0K
YoY Change 43.23% -14.71% -18.42%
Cost Of Revenue $133.0K $80.00K $93.00K
YoY Change 43.01% 0.0% 210.0%
Gross Profit $311.0K $210.0K $217.0K
YoY Change 43.32% -19.23% -38.0%
Gross Profit Margin 70.05% 72.41% 70.0%
Selling, General & Admin $3.040M $2.830M $3.819M
YoY Change -20.4% -24.33% -37.19%
% of Gross Profit 977.49% 1347.62% 1759.91%
Research & Development $979.0K $670.0K $1.457M
YoY Change -32.81% -67.32% -67.4%
% of Gross Profit 314.79% 319.05% 671.43%
Depreciation & Amortization $196.0K $220.0K $249.0K
YoY Change -21.29% -15.38% -17.0%
% of Gross Profit 63.02% 104.76% 114.75%
Operating Expenses $4.019M $3.500M $5.276M
YoY Change -23.82% -39.55% -49.99%
Operating Profit -$3.708M -$3.285M -$5.059M
YoY Change -26.7% -40.6% -50.4%
Interest Expense $210.0K $330.0K -$200.0K
YoY Change -205.0% -19.51% -91.15%
% of Operating Profit
Other Income/Expense, Net $9.000K $10.00K -$15.00K
YoY Change -160.0% -96.88% -96.05%
Pretax Income -$3.490M -$2.950M -$5.280M
YoY Change -33.9% -38.41% -58.91%
Income Tax
% Of Pretax Income
Net Earnings -$3.488M -$2.945M -$5.278M
YoY Change -33.91% -38.52% -58.93%
Net Earnings / Revenue -785.59% -1015.52% -1702.58%
Basic Earnings Per Share -$0.31 -$0.57
Diluted Earnings Per Share -$574000B -$0.31 -$0.57
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.46M $20.47M $31.25M
YoY Change -40.93% -34.5% -26.99%
Cash & Equivalents $18.46M $20.47M $31.25M
Short-Term Investments
Other Short-Term Assets $840.0K $222.0K $315.0K
YoY Change 166.67% -29.3% -81.14%
Inventory $274.0K $349.0K $620.0K
Prepaid Expenses
Receivables $312.0K $174.0K $180.0K
Other Receivables $150.0K $0.00 $300.0K
Total Short-Term Assets $20.03M $21.97M $33.35M
YoY Change -39.94% -35.45% -27.09%
LONG-TERM ASSETS
Property, Plant & Equipment $1.620M $1.798M $2.740M
YoY Change -40.88% -41.43% -27.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.620M $1.798M $2.730M
YoY Change -40.66% -41.43% -27.59%
TOTAL ASSETS
Total Short-Term Assets $20.03M $21.97M $33.35M
Total Long-Term Assets $1.620M $1.798M $2.730M
Total Assets $21.65M $23.76M $36.08M
YoY Change -39.99% -35.95% -27.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $268.0K $748.0K $330.0K
YoY Change -18.79% 28.97% -78.15%
Accrued Expenses $3.135M $3.603M $2.990M
YoY Change 4.85% 10.52% -26.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.239M $4.576M $6.210M
YoY Change -31.74% -30.98% -43.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $987.0K $1.043M $230.0K
YoY Change 329.13% 181.89% 2200.0%
Total Long-Term Liabilities $5.226M $5.619M $230.0K
YoY Change 2172.17% 1418.65% 2200.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.239M $4.576M $6.210M
Total Long-Term Liabilities $5.226M $5.619M $230.0K
Total Liabilities $9.465M $5.619M $6.430M
YoY Change 47.2% -19.73% -41.97%
SHAREHOLDERS EQUITY
Retained Earnings -$250.0M -$246.5M
YoY Change
Common Stock $122.0K $97.00K
YoY Change 15.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K $51.00K
YoY Change 0.0% 0.0%
Treasury Stock Shares $1.757K $1.757K
Shareholders Equity $16.42M $18.15M $29.65M
YoY Change
Total Liabilities & Shareholders Equity $21.65M $23.76M $36.08M
YoY Change -39.99% -35.95% -27.13%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q1
OPERATING ACTIVITIES
Net Income -$3.488M -$2.945M -$5.278M
YoY Change -33.91% -38.52% -58.93%
Depreciation, Depletion And Amortization $196.0K $220.0K $249.0K
YoY Change -21.29% -15.38% -17.0%
Cash From Operating Activities -$4.410M -$3.120M -$4.490M
YoY Change -1.78% -40.12% -58.96%
INVESTING ACTIVITIES
Capital Expenditures $45.00K -$40.00K $0.00
YoY Change 33.33% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$50.00K -$50.00K $0.00
YoY Change 66.67% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.480M 380.0K 4.500M
YoY Change -44.89% -95.99% -85.01%
NET CHANGE
Cash From Operating Activities -4.410M -3.120M -4.490M
Cash From Investing Activities -50.00K -50.00K 0.000
Cash From Financing Activities 2.480M 380.0K 4.500M
Net Change In Cash -1.980M -2.790M 10.00K
YoY Change -19900.0% -165.8% -99.95%
FREE CASH FLOW
Cash From Operating Activities -$4.410M -$3.120M -$4.490M
Capital Expenditures $45.00K -$40.00K $0.00
Free Cash Flow -$4.455M -$3.080M -$4.490M
YoY Change -0.78% -40.54% -58.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Inventory Net
InventoryNet
349000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
974000
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12169706
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q4 us-gaap Assets Current
AssetsCurrent
21966000
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1798000
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2014Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
205000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3819000
CY2014Q1 us-gaap Gross Profit
GrossProfit
217000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1457000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3135000
CY2015Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
836000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4239000
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
987000
CY2015Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5226000
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5619000
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
122000
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
266349000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-250002000
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
268000
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18462000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20469000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
312000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
174000
CY2015Q1 us-gaap Inventory Net
InventoryNet
274000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
982000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
20030000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1620000
CY2015Q1 us-gaap Assets
Assets
21650000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
16424000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21650000
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12200397
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12169706
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1757
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
444000
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
133000
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
93000
CY2015Q1 us-gaap Gross Profit
GrossProfit
311000
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3040000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
979000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
4019000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
5276000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3708000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5059000
CY2015Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-209000
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3488000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-5278000
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3502000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10857142
CY2015Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
102000
CY2015Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
22000
CY2015Q1 us-gaap Depreciation
Depreciation
196000
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
58000
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
697000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2013Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
7500000
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2600000
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5280000
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9300078
CY2014Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
178000
CY2014Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
42000
CY2014Q1 us-gaap Depreciation
Depreciation
249000
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-82000
CY2015Q1 us-gaap Other Noncash Income
OtherNoncashIncome
1000
CY2014Q1 us-gaap Other Noncash Income
OtherNoncashIncome
0
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-419000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
156000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-169000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-65000
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-99000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-877000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-512000
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-54000
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-140000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4414000
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4487000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-45000
CY2015Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2479000
CY2014Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4495000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2479000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4495000
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-27000
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-3000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2007000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31249000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31254000
CY2015Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
820000
CY2014Q1 dcth Fair Value Of Warrants Reclassified To Equity
FairValueOfWarrantsReclassifiedToEquity
116000
CY2015Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0625
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
166000
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
203000
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
72000
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
63000
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
36000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
83000
CY2015Q1 us-gaap Prepaid Insurance
PrepaidInsurance
394000
CY2014Q4 us-gaap Prepaid Insurance
PrepaidInsurance
591000
CY2015Q1 dcth Kits For Clinical Use
KitsForClinicalUse
145000
CY2014Q4 dcth Kits For Clinical Use
KitsForClinicalUse
161000
CY2015Q1 us-gaap Prepaid Taxes
PrepaidTaxes
143000
CY2014Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5000
CY2015Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
300000
CY2014Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
217000
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5547000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5546000
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3927000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3748000
CY2015Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1937000
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2187000
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
249000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
341000
CY2015Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1300000
CY2013Q4 dcth Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
6900000
CY2015Q1 dcth Short Term Portion Of Lease Restructuring
ShortTermPortionOfLeaseRestructuring
209000
CY2014Q4 dcth Short Term Portion Of Lease Restructuring
ShortTermPortionOfLeaseRestructuring
239000
CY2015Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
43000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
778000
CY2012Q2 dcth Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
21100000
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1000000
CY2012Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
21500000
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2500000
CY2015Q1 dcth Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
2500000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
40000
CY2015Q1 dcth Number Of Inputs Used For Valuation Of Warrants
NumberOfInputsUsedForValuationOfWarrants
6
CY2015Q1 dcth Hypothetical Change In Market Price Of Common Shares
HypotheticalChangeInMarketPriceOfCommonShares
0.10
CY2015Q1 dcth Impact Of Hypothetical Change In Market Price Of Common Shares On Derivative Liability
ImpactOfHypotheticalChangeInMarketPriceOfCommonSharesOnDerivativeLiability
100000
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
225000
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
209000
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
820000
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
836000
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2260320
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1147860

Files In Submission

Name View Source Status
0001564590-15-003441-index-headers.html Edgar Link pending
0001564590-15-003441-index.html Edgar Link pending
0001564590-15-003441.txt Edgar Link pending
0001564590-15-003441-xbrl.zip Edgar Link pending
dcth-10q_20150331.htm Edgar Link pending
dcth-20150331.xml Edgar Link completed
dcth-20150331.xsd Edgar Link pending
dcth-20150331_cal.xml Edgar Link unprocessable
dcth-20150331_def.xml Edgar Link unprocessable
dcth-20150331_lab.xml Edgar Link unprocessable
dcth-20150331_pre.xml Edgar Link unprocessable
dcth-ex311_201503316.htm Edgar Link pending
dcth-ex312_201503317.htm Edgar Link pending
dcth-ex321_201503318.htm Edgar Link pending
dcth-ex322_201503319.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending